NC
CL icon

Northcape Capital’s Colgate-Palmolive CL Stock Holding History

Northcape Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$547K Buy
6,012
+282
+5% +$26.9K 0.09% 28
2024
Q3 		$595K Sell
5,730
-3,131
-35% -$319K 0.09% 31
2024
Q2 		$860K Sell
8,861
-5,083
-36% -$469K 0.13% 26
2024
Q1 		$1.26M Sell
13,944
-418
-3% -$35.4K 0.14% 26
2023
Q4 		$1.15M Sell
14,362
-2,759
-16% -$207K 0.14% 25
2023
Q3 		$1.22M Buy
17,121
+4,450
+35% +$333K 0.18% 22
2023
Q2 		$976K Sell
12,671
-4,592
-27% -$355K 0.12% 24
2023
Q1 		$1.3M Sell
17,263
-4,955
-22% -$368K 0.16% 23
2022
Q4 		$1.75M Buy
22,218
+665
+3% +$49.9K 0.22% 17
2022
Q3 		$1.51M Sell
21,553
-4,906
-19% -$385K 0.19% 16
2022
Q2 		$2.12M Buy
26,459
+1,413
+6% +$110K 0.27% 16
2022
Q1 		$1.9M Buy
25,046
+7,115
+40% +$564K 0.19% 21
2021
Q4 		$1.53M Sell
17,931
-16,771
-48% -$1.31M 0.16% 23
2021
Q3 		$2.45M Buy
+34,702
New +$2.76M 0.26% 21
2020
Q3 		– Sell
-314,968
Closed -$23.1M – 25
2020
Q2 		$23.1M Buy
314,968
+115
+0% +$8.17K 3.46% 6
2020
Q1 		$20.9M Buy
314,853
+92,751
+42% +$6.54M 4.26% 5
2019
Q4 		$15.3M Sell
222,102
-48,293
-18% -$3.29M 2.45% 6
2019
Q3 		$19.9M Buy
270,395
+92,151
+52% +$6.69M 3.5% 6
2019
Q2 		$12.8M Sell
178,244
-14,402
-7% -$1.02M 2.32% 7
2019
Q1 		$13.2M Buy
192,646
+936
+0.5% +$60.5K 2.69% 7
2018
Q4 		$11.4M Sell
191,710
-57,485
-23% -$3.6M 2.73% 7
2018
Q3 		$16.7M Buy
249,195
+16,369
+7% +$1.09M 4.66% 7
2018
Q2 		$15.1M Sell
232,826
-29,999
-11% -$1.96M 4.1% 8
2018
Q1 		$18.8M Sell
262,825
-94,665
-26% -$6.81M 4.68% 8
2017
Q4 		$27M Sell
357,490
-238,945
-40% -$17.4M 6.8% 7
2017
Q3 		$43.5M Buy
596,435
+8,347
+1% +$602K 11.96% 3
2017
Q2 		$43.6M Sell
588,088
-24,392
-4% -$1.81M 12.91% 3
2017
Q1 		$44.8M Buy
612,480
+76,637
+14% +$5.36M 13.21% 4
2016
Q4 		$35.1M Buy
+535,843
New +$36.7M 12.65% 5

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Northcape Capital's CL Position: Q4 2024 in Review

Northcape Capital increased its Colgate-Palmolive (CL) stake by 4.9% in Q4 2024, buying an estimated $26.9K and bringing the position to 6,012 shares worth $547K. The position accounts for 0.09% of the portfolio, ranked #28.

Northcape Capital first reported a position in CL in Q4 2016 and has held it in 29 quarters since. The position peaked at $44.8M in Q1 2017. 1,935 funds tracked by Wall St. Rank hold CL as of Q4 2024.

  • Northcape Capital held 6,012 shares of Colgate-Palmolive worth $547K as of Q4 2024.
  • Northcape Capital bought 282 Colgate-Palmolive shares in Q4 2024, an estimated $26.9K.
  • Colgate-Palmolive made up 0.09% of Northcape Capital's portfolio in Q4 2024, its #28 holding.
  • Northcape Capital first reported a position in Colgate-Palmolive in Q4 2016 and has held it in 29 quarters since.
  • Northcape Capital's Colgate-Palmolive position peaked at $44.8M in Q1 2017.
  • 1,935 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2024.

Based on Northcape Capital's 13F filing for Q4 2024, filed 8 Jan 2025.